Health Care & Life Sciences » Pharmaceuticals | Hyundai Pharmaceutical Co. Ltd.

Hyundai Pharmaceutical Co. Ltd.

Hyundai Pharmaceutical Co. Ltd.
Stock Exchange Korea Exchange Commodity Market
EPS
KRW40.93
Market Cap
KRW131.7 B
Shares Outstanding
32 M
Public Float
19.34 M

Profile

Address
55 Jandari-gil
Cheonan SC 31213
Korea, Republic Of
Employees -
Website http://www.hyundaipharm.co.kr
Updated 07/08/2019
Hyundai Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products, health food drinks and medical equipment. Its major products include ethical drugs (ETC) and over-the-counter (OTC) drugs. The company was founded on July 16, 1965 and is headquartered in Cheonan, South Korea.

Financials

View All

Han-Gu Lee
Chairman & Co-Chief Executive Officer
Young-Hak Kim
President, Co-Chief Executive Officer & Director